ClinicalTrials.gov record
Active, not recruiting No phase listed Observational

Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy

ClinicalTrials.gov ID: NCT05699460

Public ClinicalTrials.gov record NCT05699460. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 8:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Pre-Gene Therapy Study of Early Parkinson's or Multiple System Atrophy Progression by Longitudinal Clinical and Biomarker Assessments

Study identification

NCT ID
NCT05699460
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
AskBio Inc
Industry
Enrollment
150 participants

Conditions and interventions

Interventions

  • This is an observational study. Other

Other

Eligibility (public fields only)

Age range
35 Years to 75 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 28, 2022
Primary completion
Oct 31, 2025
Completion
Oct 31, 2025
Last update posted
Oct 1, 2025

2022 – 2025

United States locations

U.S. sites
7
U.S. states
7
U.S. cities
7
Facility City State ZIP Site status
University of California Irvine Irvine California 92697
Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton Florida 33486
Massachusetts General Hospital Boston Massachusetts 02114
Quest Research Institute Farmington Hills Michigan 48334
Ohio Health Research Institute Columbus Ohio 43214
OHSU Parkinson Center & Movement Disorders Program Portland Oregon 97239
Vanderbilt University Medical Center Nashville Tennessee 37232

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05699460, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 1, 2025 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05699460 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →